Lymphangioma overview: Difference between revisions

Jump to navigation Jump to search
Line 8: Line 8:


==Pathophysiology==
==Pathophysiology==
* [[Lymphangioma]] arises from [[lymph]] vessels, which are normally involved in the re-circulation of excess body [[fluid]] back into the [[blood]] stream.<ref name="pmid18500536">{{cite journal |vauthors=Wiegand S, Eivazi B, Barth PJ, von Rautenfeld DB, Folz BJ, Mandic R, Werner JA |title=Pathogenesis of lymphangiomas |journal=Virchows Arch. |volume=453 |issue=1 |pages=1–8 |date=July 2008 |pmid=18500536 |doi=10.1007/s00428-008-0611-z |url=}}</ref>
Lymphangioma arises from [[lymph]] vessels, which are normally involved in the re-circulation of excess body [[fluid]] back into the [[blood]] stream. The exact [[pathogenesis]] of [[lymphangioma]] is not fully understood. It is thought that [[lymphangioma]] is caused by either sequestration of [[lymph]] tissue, abnormal [[budding]] of [[lymph]] vessels, lack of fusion with the [[venous]] system, or obstruction of [[lymph]] vessels. [[Lymphangiomas]] most commonly develop at the [[head]] and [[neck]] regions. [[Lymphangioma]] is associated with a number of conditions that include [[Turner syndrome]] and [[Down syndrome]]. On gross pathology, characteristic findings of [[lymphangioma]] include a grey-white, well circumscribed, edematous mass with a variable size and consistency. On microscopic [[histopathological]] analysis, characteristic findings of [[lymphangioma]] include thin walled [[endothelial]] lining, [[intraluminal]]<nowiki/>accumulation of [[eosinophilic]] deposits, and clusters of [[intraluminal]] [[Lymphocyte|lymphocytes]].
* The exact mechanism of development of abnormal [[malformations]] is not known.
* It is suggested that [[lymphangioma]] is formed as a result of one of four mechanisms:<ref name="pmid26967121">{{cite journal |vauthors=Chang MB, Newman CC, Davis MD, Lehman JS |title=Acquired lymphangiectasia (lymphangioma circumscriptum) of the vulva: Clinicopathologic study of 11 patients from a single institution and 67 from the literature |journal=Int. J. Dermatol. |volume=55 |issue=9 |pages=e482–7 |date=September 2016 |pmid=26967121 |doi=10.1111/ijd.13264 |url=}}</ref>
** Sequestration of [[lymph]] tissue
** Abnormal [[budding]] of [[lymph]] vessels
** Lack of fusion with the [[venous]] system
** Obstruction of [[lymph]] vessels
 
*Whimster describes [[pathogenesis]] of [[lymphangioma]] as the collection of [[Lymphatic drainage|lymphatic cisterns]] in the deep [[Subcutaneous tissue|subcutaneous]] plane which get detached from normal [[Network motif|network]], however they keep connected to [[superficial]]  [[lymph]] [[vessels]] through short and [[Vessels|dilated vessels]].<ref name="pmid27134953">{{cite journal |vauthors=Ersoy AO, Oztas E, Saridogan E, Ozler S, Danisman N |title=An Unusual Origin of Fetal Lymphangioma Filling Right Axilla |journal=J Clin Diagn Res |volume=10 |issue=3 |pages=QD09–11 |date=March 2016 |pmid=27134953 |pmc=4843338 |doi=10.7860/JCDR/2016/18516.7513 |url=}}</ref>
 
* The cisterns originally [[Derived|derive]] from [[Primitive (integral)|primitive]] [[lymph]] sac, which fail to connect to normal [[Circulatory system|circulation]].
* These are covered with thick [[muscular]] coat, which on [[contraction]] increase intramural [[Pressure|pressure.]]
* Ultimately leads to dilated sacs which are visible on [[skin]] as out-pouchings.
* Whimster's description is proved with radio-graphic evidence as well.<ref name="pmid15149994">{{cite journal |vauthors=Levy AD, Cantisani V, Miettinen M |title=Abdominal lymphangiomas: imaging features with pathologic correlation |journal=AJR Am J Roentgenol |volume=182 |issue=6 |pages=1485–91 |date=June 2004 |pmid=15149994 |doi=10.2214/ajr.182.6.1821485 |url=}}</ref>
** Which showed large multilobulated cisterns extend deep in the [[dermis]] and laterally beyond the [[clinical]] lesions.  
** These deep [[Lymphangioma|lymphangiomas]] had no connections with the adjacent normal [[Lymphatic system|lymphatics.]]
 
* Some [[Lymphangioma|lymphangiomas]] may represent [[vascular malformation]]<nowiki/>s during [[embryonic development]] rather than as [[Neoplasm|true neoplasms.]]
* For more information on Vascular anamolies'''. [[Vascular anomalies|Click here.]]'''
* Vascular endothelial growth factor (VEGF)–C and VEGF receptor-3 play a key role in development of lymphangiomas.<ref name="pmid163552142">{{cite journal |vauthors=Ferrara N, Kerbel RS |title=Angiogenesis as a therapeutic target |journal=Nature |volume=438 |issue=7070 |pages=967–74 |date=December 2005 |pmid=16355214 |doi=10.1038/nature04483 |url=}}</ref>
**Acquired lymphangiomas <ref name="pmid29186257">{{cite journal |vauthors=Oliveti A, Biasi TB, Funchal GDG |title=Lymphangioma secondary to irradiation after mastectomy |journal=An Bras Dermatol |volume=92 |issue=3 |pages=395–397 |date=2017 |pmid=29186257 |pmc=5514585 |doi=10.1590/abd1806-4841.20173952 |url=}}</ref>
**Acquired lymphangioms arise as a cosequence of any interruption of previously normal lymphatic drainage such as surgery<ref name="pmid28913305">{{cite journal |vauthors=Hwang J, Lee YK, Burm JS |title=Treatment of Tongue Lymphangioma with Intralesional Combination Injection of Steroid, Bleomycin and Bevacizumab |journal=Arch Craniofac Surg |volume=18 |issue=1 |pages=54–58 |date=March 2017 |pmid=28913305 |pmc=5556746 |doi=10.7181/acfs.2017.18.1.54 |url=}}</ref>, trauma, Infection, malignancy, and radiation therapy.<ref name="pmid29186257">{{cite journal |vauthors=Oliveti A, Biasi TB, Funchal GDG |title=Lymphangioma secondary to irradiation after mastectomy |journal=An Bras Dermatol |volume=92 |issue=3 |pages=395–397 |date=2017 |pmid=29186257 |pmc=5514585 |doi=10.1590/abd1806-4841.20173952 |url=}}</ref>


==Causes==  
==Causes==  

Revision as of 16:57, 10 December 2018

Lymphangioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lymphangioma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphangioma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphangioma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphangioma overview

CDC on Lymphangioma overview

Lymphangioma overview in the news

Blogs on Lymphangioma overview

Directions to Hospitals Treating Lymphangioma

Risk calculators and risk factors for Lymphangioma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2] Badria Munir M.B.B.S.[3]

Overview

Lymphangioma arises from lymph vessels, which are normally involved in the re-circulation of excess body fluid back into the blood stream. The exact pathogenesis of lymphangioma is not fully understood. It is thought that lymphangioma is caused by either sequestration of lymph tissue, abnormal budding of lymph vessels, lack of fusion with the venous system, or obstruction of lymph vessels. Lymphangiomas most commonly develop at the head and neck regions. Lymphangioma is associated with a number of conditions that include Turner syndrome and Down syndrome. On gross pathology, characteristic findings of lymphangioma include a grey-white, well circumscribed, edematous mass with a variable size and consistency. On microscopic histopathological analysis, characteristic findings of lymphangioma include thin walled endothelial lining, intraluminal accumulation of eosinophilic deposits, and clusters of intraluminal lymphocytes. There are no known direct causes for lymphangioma. Lymphangioma must be differentiated from arteriovenous malformation, branchial cleft cyst, and dermoid cyst. Lymphangiomas are rare, accounting for 4% of all vascular tumors among children. The incidence of lymphangioma is estimated to be less than 2 cases per 100,000 individuals in the United States. Lymphangioma commonly affects individuals younger than 5 years of age. Lymphangioma affects men and women equally. There is no racial predilection to the lymphangioma. CT scan may be diagnostic of lymphangioma. Findings on CT scan suggestive of lymphangioma include a homogeneous, cystic, mass that may demonstrate intrinsic septations and compression of adjacent organs. The mainstay of therapy for lymphangioma is surgery. Treatment for lymphangioma involves the removal of the abnormal tissue; however complete removal may be impossible without removing other normal areas. Most patients need at least two procedures done for the removal process to be achieved.


Pathophysiology

Lymphangioma arises from lymph vessels, which are normally involved in the re-circulation of excess body fluid back into the blood stream. The exact pathogenesis of lymphangioma is not fully understood. It is thought that lymphangioma is caused by either sequestration of lymph tissue, abnormal budding of lymph vessels, lack of fusion with the venous system, or obstruction of lymph vessels. Lymphangiomas most commonly develop at the head and neck regions. Lymphangioma is associated with a number of conditions that include Turner syndrome and Down syndrome. On gross pathology, characteristic findings of lymphangioma include a grey-white, well circumscribed, edematous mass with a variable size and consistency. On microscopic histopathological analysis, characteristic findings of lymphangioma include thin walled endothelial lining, intraluminalaccumulation of eosinophilic deposits, and clusters of intraluminal lymphocytes.

Causes

Differentiating Lymphangioma from other Diseases

Lymphangioma must be differentiated from arteriovenous malformation, branchial cleft cyst, and dermoid cyst.

Epidemiology and Demographics

  • Lymphangiomas are rare, accounting for 4% of all vascular tumors among children.[2]
  • The incidence of lymphangioma is estimated to be less than 2 cases per 100,000 individuals in the United States.
  • Lymphangioma commonly affects individuals younger than 5 years of age.
  • Lymphangioma affects men and women equally.
  • There is no racial predilection to the lymphangioma.

Risk Factors

The most potent risk factor in the development of lymphangioma is the presence of genetic disorders such as Turner syndrome, Down syndrome, and Noonan syndrome.[1]

Natural History, Complications and Prognosis

  • Most of the patients with lymphangioma will develop a cervico-facial mass that often grows in proportion to the patient’s body growth rate.
  • The mass usually recurs after surgical interventions.
  • Common complications of lymphangioma include esophageal obstruction, upper respiratory tract obstruction, infections, and compression of adjacent tissues such as nerves and blood vessels. Prognosis of lymphangioma is generally excellent.

Diagnosis

History and Symptoms:

  • The majority of patients with lymphangioma are asymptomatic.

Physical Exam:

  • Lymphangioma patients often appear healthy. On physical exam a painless , compressible, soft neck mass that often transilluminates is a diagnostic finding on physical exam.

Laboratory Findings:

  • There are no diagnostic lab findings associated with lymphangioma.

CT Scan:

  • CT scan may be diagnostic of lymphangioma. Findings on CT scan suggestive of lymphangioma include a homogeneous, cystic, mass that may demonstrate intrinsic septations and compression of adjacent organs.

MRI:

  • MRI may be diagnostic of lymphangioma. Findings on MRI suggestive of lymphangioma include hyperintense signal enhancement due to cyst formation.

Other Diagnostic Studies:

Treatment

Medical Therapy:

  • There is no medical treatment for lymphangioma; the mainstay of therapy is surgery.

Surgery:

  • The mainstay of therapy for lymphangioma is surgery. Treatment for lymphangioma involves the removal of the abnormal tissue; however complete removal may be impossible without removing other normal areas. Most patients need at least two procedures done for the removal process to be achieved.

References

  1. 1.0 1.1 Pootrakul L, Nazareth MR, Cheney RT, Grassi MA (June 2014). "Lymphangioma circumscriptum of the vulva in a patient with Noonan syndrome". Cutis. 93 (6): 297–300. PMID 24999641.
  2. Ersoy AO, Oztas E, Saridogan E, Ozler S, Danisman N (March 2016). "An Unusual Origin of Fetal Lymphangioma Filling Right Axilla". J Clin Diagn Res. 10 (3): QD09–11. doi:10.7860/JCDR/2016/18516.7513. PMC 4843338. PMID 27134953.


Template:WikiDoc Sources